VivoSim Labs, Inc. (VIVS)
NASDAQ: VIVS · Real-Time Price · USD
2.000
+0.130 (6.96%)
Apr 25, 2025, 4:00 PM EDT - Market closed
VivoSim Labs Employees
As of March 31, 2024, VivoSim Labs had 20 total employees, including 12 full-time and 8 part-time employees. The number of employees decreased by 4 or -16.67% compared to the previous year.
Employees
20
Change (1Y)
-4
Growth (1Y)
-16.67%
Revenue / Employee
$6,100
Profits / Employee
-$619,250
Market Cap
3.40M
Employees Chart
VIVS News
- 1 day ago - VivoSim Announces Emergence from Stealth Mode To Provide Technologies for FDA Turn Away from Animal Models, $10B+ Market - GlobeNewsWire
- 2 days ago - VivoSim to Carry Forward Organovo 3D Bioprinting - GlobeNewsWire
- 23 days ago - Organovo Provides Update on Cash and Nasdaq Continued Listing Requirements - GlobeNewsWire
- 4 weeks ago - Organovo Provides Business Update - GlobeNewsWire
- 4 weeks ago - Organovo Announces Close of the Sale of FXR Program to Eli Lilly and Company - GlobeNewsWire
- 5 weeks ago - Organovo Announces Reverse Stock Split - GlobeNewsWire
- 6 weeks ago - Matinas BioPharma Appoints Seasoned Biotech Leaders to Board of Directors - GlobeNewsWire
- 7 weeks ago - Organovo Announces the Issuance of Additional Shares in Conjunction with Warrant Exercises - GlobeNewsWire